Taste test: could your food cravings predict malnutrition during cancer treatment?
NCT ID NCT05496556
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether food preferences can help predict undernutrition in people with stage IV non-small cell lung cancer who are starting their first treatment. About 190 participants will have their food cravings measured and receive personalized dietary advice if needed. The goal is to better understand and manage nutrition during cancer care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 190 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2023
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of stage IV non-small cell lung carcinoma with indication for first-line systemic treatment (chemotherapy, immunotherapy or specific treatment, in particular tyrosine kinase inhibitors) according to current French recommendations. * Age over 18 and under 70 * Patient speaking and reading French fluently * Affiliation to a social security scheme * Patient able and willing to follow all study procedures in accordance with the protocol * Patient having understood, signed and dated the consent form Exclusion Criteria: * Patient requiring hospitalization for more than 48 hours for the administration of the first course of treatment * Patient benefiting from antibiotic therapy for the treatment of an acute infection * Psychiatric, cognitive or neurological disorders making it impossible to assess food preferences and/or any impossibility to undergo medical monitoring for the trial for geographical, social or psychological reasons. * Daily alcohol consumption * Chest radiotherapy treatment * Pregnant woman, likely to be, or breastfeeding * Persons deprived of liberty or under guardianship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-small cell bronchopulmonary carcinoma at stage IV and benefiting from first-line treatment according to current french recommendations are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Georges-François Leclerc
Dijon, Côte d'Or, 21000, France